6:00 pm Merck: FDA approves GRASTEK (Timothy Grass Pollen Allergen Extract) tablets as immunotherapy to treat grass pollen-induced allergic rhinitis with or without conjunctivitis in children and adults
View todays social media effects on MRK
View the latest stocks trending across Twitter. Click to view dashboard
See who Merck is hiring next, click here to view
